US FDA Needs More Time To Review Clinuvel’s Scenesse For Phototoxicity

 
• By Ian Schofield
  
Delayed
The FDA has extended the review deadline for Scenesse
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United States

More from North America